<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>25(1)</volume><submitter>Suzuki M</submitter><pubmed_abstract>&lt;h4>Background and objective&lt;/h4>Hemoptysis is a life-threatening condition requiring urgent treatment. Bronchial artery embolization (BAE), established as the primary intervention, is an effective treatment for hemoptysis. Common etiologies include bronchiectasis, tumors, tuberculosis, aspergilloma, and cystic fibrosis. Approximately 20% of hemoptysis cases are categorized as cryptogenic. We conducted a retrospective observational study to understand the clinical characteristics of patients with cryptogenic hemoptysis (CH).&lt;h4>Methods&lt;/h4>The clinical characteristics, angiographic findings, and immediate and long-term efficacies of BAE were retrospectively analyzed in 36 consecutive patients between January 2010 and December 2022. Superselective BAE was successfully performed in all patie</pubmed_abstract><journal>BMC pulmonary medicine</journal><pagination>480</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12539079</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical analysis of the efficacy of bronchial artery embolization with gelatin sponge in our hospital for cryptogenic hemoptysis: a single-center, retrospective, observational study.</pubmed_title><pmcid>PMC12539079</pmcid><pubmed_authors>Kusaba Y</pubmed_authors><pubmed_authors>Suzuki M</pubmed_authors><pubmed_authors>Izumi S</pubmed_authors><pubmed_authors>Sugiyama H</pubmed_authors><pubmed_authors>Takeda Y</pubmed_authors><pubmed_authors>Naka G</pubmed_authors><pubmed_authors>Nokihara H</pubmed_authors><pubmed_authors>Hojo M</pubmed_authors><pubmed_authors>Hatano S</pubmed_authors><pubmed_authors>Ishida A</pubmed_authors><pubmed_authors>Hashimoto M</pubmed_authors><pubmed_authors>Tsukada A</pubmed_authors><pubmed_authors>Morita C</pubmed_authors><pubmed_authors>Takasaki J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical analysis of the efficacy of bronchial artery embolization with gelatin sponge in our hospital for cryptogenic hemoptysis: a single-center, retrospective, observational study.</name><description>&lt;h4>Background and objective&lt;/h4>Hemoptysis is a life-threatening condition requiring urgent treatment. Bronchial artery embolization (BAE), established as the primary intervention, is an effective treatment for hemoptysis. Common etiologies include bronchiectasis, tumors, tuberculosis, aspergilloma, and cystic fibrosis. Approximately 20% of hemoptysis cases are categorized as cryptogenic. We conducted a retrospective observational study to understand the clinical characteristics of patients with cryptogenic hemoptysis (CH).&lt;h4>Methods&lt;/h4>The clinical characteristics, angiographic findings, and immediate and long-term efficacies of BAE were retrospectively analyzed in 36 consecutive patients between January 2010 and December 2022. Superselective BAE was successfully performed in all patie</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T16:17:36.122Z</modification><creation>2026-05-13T14:23:54.131Z</creation></dates><accession>S-EPMC12539079</accession><cross_references><pubmed>41121032</pubmed><doi>10.1186/s12890-025-03948-8</doi></cross_references></HashMap>